Insider Trading & Ownership of Michael Aaron Kelly

Location: New York, NY
Summary: The estimated net worth of Michael Aaron Kelly is at least $1.66M dollars as of 05 Aug 2025. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $785K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $450K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $410K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
Signature: /s/ Ryan Brown, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Michael Aaron Kelly files a new Insider Trading report.

Ownership of Michael Aaron Kelly

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NEO	NEOGENOMICS INC	Director	$785K	+$38K	+5.09%	01 Jun 2025
FOLD	AMICUS THERAPEUTICS, INC.	Director	$450K			05 Jun 2025
BOOM	DMC Global Inc.	Director	$410K			14 May 2025
APRE	Aprea Therapeutics, Inc.	Director	$17K			30 Jun 2021
HOOK	HOOKIPA Pharma Inc.	Director				30 Jun 2022
PRME	Prime Medicine, Inc.	Director				01 Aug 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.